Circulating antibodies to endogenous erythropoietin and risk for HIV-1-related anemia

Journal of Infection

Volumn 60, Issue 3, 2010, Pages 238-243

  Tsiakalos, Aristotelis ^a   Kordossis, Theodore ^a   Ziakas, Panayiotis D ^a   Kontos, Athanasios N ^a   Kyriaki, Despina ^b   Sipsas, Nikolaos V ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Anemia; Autoantibodies; Erythropoietin; HIV 1

Indexed keywords

AUTOANTIBODY; ERYTHROPOIETIN ANTIBODY; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ANEMIA; ANTIBODY DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RISK FACTOR;

ADULT; ANEMIA; AUTOANTIBODIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS;

EID: 76849117293     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.12.013     Document Type: Article

References (27)

1. Belperio P.S., Rhew D.C. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004, 116:27-43.
2. Sullivan P.S., Hanson D.L., Chu S.Y., Jones J.L., Ward J.W. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons. Results from a multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998, 91:301-308. for the Adult/Adolescent Spectrum of Disease Group.
3. Mildvan D., Creagh T., Leitz G. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin 2007, 23:343-355.
4. Kreuzer K.A., Rockstroh J.K. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997, 75:179-187.
5. Calore E.E., Tanaka P.Y., Perez N.M., de Almeida L.V. Bone marrow pathology in AIDS. Pathol Res Pract 2004, 200:591-597.
6. Spivac J.L., Barnes D.C., Fuchs E., Quinn T.A. Serum immunoreactive erythropoietin in HIV-1 infected patients. JAMA 1989, 261:3104-3107.
7. Kreuzer K.A., Rockstroh J.K., Jelkmann W., Theisen A., Spengler U., Sauerbruch T. Inadequate erythropoietin response to anemia in HIV patients: relationship to serum levels of tumor necrosis factor-alpha, interleukin 6 and their soluble receptors. Br J Haematol 1997, 96:235-239.
8. Saif M.W. HIV-associated autoimmune hemolytic anemia: an update. AIDS Patient Care STDS 2001, 15:217-224.
9. Herzlich B.C., Schiano T.D., Moussa Z., Zimbalist E., Panagopoulos G., Ast A., et al. Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. Am J Gastroenterol 1992, 87:1781-1788.
10. Montero A., Giovannoni A.G., Fernandez M.A., Pons-Estel B., Sen L. Autoantibodies in human immunodeficiency virus-infected patients with and without concurrent hepatitis C infection. Arthritis Rheum 1998, 41:2077-2079.
11. Kordossis T., Piha L., Guialis A., Kosmopoulou O., Tzioufas A.G., Moutsopoulos H.M. Non-organ specific autoantibodies against cellular components in HIV-1 infected individuals. Clin Exp Rheumatol 1997, 15:185-188.
12. Williams W.M., Whalley A.S., Comacchio R.M., Rosenberg J., Watts R.A., Isenberg D.A., et al. Correlation between expression of antibodies to histone H2B and clinical activity in HIV-infected individuals. Clin Exp Immunol 1996, 104:18-24.
13. Massabki P.S., Accetturi C., Nishie I.A., da Silva N.P., Sato E.I., Andrade L.E.C. Clinical implications of autoantibodies in HIV infection. AIDS 1997, 11:1845-1850.
14. Sipsas N.V., Kokori S.I., Ioannidis J.P.A., Kyriaki D., Tzioufas A.G., Kordossis T. Circulating autoantibodies to erythropoietin are associated with HIV-1 related anaemia. J Infect Dis 1999, 180:2044-2047.
15. Tzioufas A.G., Kokori S.I., Petrovas C.I., Moutsopoulos H.M. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:2212-2216.
16. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1998, 44:1049-1060.
17. Lipsitz S.R., Fitzmaurice G.M., Orav E.J., Laird N.M. Performance of generalized estimating equations in practical situations. Biometrics 1994, 50:270-278.
18. Majluf-Cruz A., Luna-Castanos G., Nieto-Cisneros L. AIDS-related pure red cell aplasia. Am J Hematol 1996, 51:171.
19. Ziakas P.D., Papadaki H., Psyllaki M., Voulgarelis M. Anti-thrombopoietin antibodies suppress megakaryocytic colony formation in vitro in patients with systemic lupus erythematosus. Ann Rheum Dis 2008, 67:1643-1644.
20. Casadevall N., Dupuy E., Molho-Sabatier P., Tobelem G., Varet B., Mayeux P. Autoantibodies against erythropoietin in a patient with pure red cell aplasia. N Engl J Med 1996, 334:630-633.
21. Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol 1994, 68:215-223.
22. Fischl M., Galpin J.E., Levine J.D., Groopman J.E., Henry D.H., Kennedy P., et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990, 322:1488-1493.
23. Chng W.J., Tan L.K., Liu T.C. Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy. Am J Kidney Dis 2003, 41:692-695.
24. Sawada K., Fujishima N., Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008, 142:505-514.
25. Semba R.D., Shah N., Klein R.S., Mayer K.H., Scuman P., Vlahov D. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS 2001, 15:473-480. Human Immunodeficiency Virus Epidemiology Research Study Group.
26. Moore R.D., Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002, 29:54-57.
27. Semba R.D., Shah N., Vlahov D. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001, 26:315-319.